Pharmagen Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Mar '14 Mar 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010
Cash & Equivalents	0.26	0.23	0.32	0.04	0.01
Cash & Short-Term Investments	0.26	0.23	0.32	0.04	0.01
Cash Growth	-59.09%	-29.94%	734.38%	467.50%	-
Receivables	0.33	0.37	0.64	0.21	0.05
Inventory	0.17	0.14	0.15	0.01	0.06
Prepaid Expenses	0.08	0.06	0.28	0.01	-
Other Current Assets	-	0.09	0.2	-	-
Total Current Assets	0.84	0.88	1.59	0.27	0.11
Property, Plant & Equipment	0.42	0.38	0.09	0.03	-
Goodwill	-	-	1.2	-	-
Other Intangible Assets	0.02	0.02	0.02	-	-
Total Assets	1.28	1.28	2.9	0.3	0.11
Accounts Payable	1.73	1.38	0.78	0.2	0.05
Short-Term Debt	0.52	1.66	1.29	0.48	0.13
Current Portion of Long-Term Debt	2.04	2.16	0.25	-	-
Current Portion of Leases	0.04	0.04	-	-	-
Other Current Liabilities	3.97	2.86	0.11	-	-
Total Current Liabilities	8.29	8.1	2.43	0.67	0.19
Long-Term Debt	0.52	0.5	1.25	-	-
Long-Term Leases	0.27	0.27	-	-	-
Other Long-Term Liabilities	-	-	1.9	-	-
Total Liabilities	9.08	8.87	5.59	0.67	0.19
Common Stock	0.51	0.43	0.38	0.2	0
Additional Paid-In Capital	1.32	1.48	0.17	-	-
Retained Earnings	-9.86	-9.15	-3.15	-0.38	-0.08
Comprehensive Income & Other	-	-0.48	-0.09	-0.2	-
Total Common Equity	-8.03	-7.72	-2.69	-0.37	-0.08
Shareholders' Equity	-7.8	-7.59	-2.69	-0.37	-0.08
Total Liabilities & Equity	1.28	1.28	2.9	0.3	0.11
Total Debt	3.39	4.63	2.79	0.48	0.13
Net Cash (Debt)	-3.13	-4.4	-2.47	-0.44	-0.13
Net Cash Per Share	-0.01	-0.01	-0.01	-0.00	-
Filing Date Shares Outstanding	517.08	498.58	381.13	200	-
Total Common Shares Outstanding	504.45	434.41	381.13	200	-
Working Capital	-7.46	-7.22	-0.85	-0.4	-0.08
Book Value Per Share	-0.02	-0.02	-0.01	-0.00	-
Tangible Book Value	-8.05	-7.74	-3.92	-0.37	-0.08
Tangible Book Value Per Share	-0.02	-0.02	-0.01	-0.00	-

Source: S&P Capital IQ. Standard template. Financial Sources.